Assessing cardiovascular risk in hepatitis C: An unmet need.

For all these reasons, patients with adrenal insufficiency may be at higher risk of medical complications and eventually at increased mortality risk in the case

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart

Of note, higher levels of inflammatory (IL-6, hs-CRP) and coagulation (D-dimer) markers are associated with an increased risk of cardiovascular disease (CVD) (26), cancer (27),

Methods and Results- —We studied cardiovascular disease risk factor changes in the START (Strategic Timing of Antiretroviral Treatment) trial, a randomized study of immediate

An increased risk of acute myocardial infarction and heart failure is observed with all NSAIDs, while an elevated risk of hemorrhagic stroke appears to be restricted to the use

NSAIDs increase the risk of cardiovascular disease in the general population, and although there is little direct evidence for elevated cardiovascular risk with NSAIDs in people

C-reactive pmtein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina J Am Coll Cardiol2002;39(4):632-7. C-

Fortunately, physicians appear to be aware of the need to monitor CVD risk in patients with active RA: a study of 14,503 patients in world-wide data from the SUrvey of